T Cell Clones Generated from Patients with Type 1 Diabetes Using Interleukin-2 Proliferate to Human Islet Antigens

References

• Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Eng J Med 1985; 313: 353–60
   PubMed Web of Science ®Google Scholar
• Wicker LS, Miller BJ, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35: 855–60
   PubMed Web of Science ®Google Scholar
• Koevary S, Rossini AA, Stoller W, Chick W, Williams RM. Passive transfer of diabetes in the BB/W rat. Science 1983; 220: 727–8
   PubMed Web of Science ®Google Scholar
• Sibley RK, Sutherland DER, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53: 132–44
   PubMed Web of Science ®Google Scholar
• Peakman M, Alviggi L, Hussain MJ, Pyke DA, Leslie RDG, Vergani D. Persistent T cell activation predicts progression to diabetes in non-diabetic, identical co-twins of insulin dependent diabetics. Diabetologia 1991; 34: A56
   Google Scholar
• Alviggi L, Johnston C, Hoskins PJ, Tee DEH, Pyke DA, Leslie RDG. Pathogenesis of insulin dependent diabetes: a role for activated T lymphocytes. Lancet 1984; ii: 4–5
   Google Scholar
• Jackson RA, Morris MA, Haynes BF, Eisenbarth GS. Increased circulating la-antigen bearing T cells in type I diabetes mellitus. N EnglJ Med 1982; 306: 785–88
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer KM. Monoclonal antibodies defined abnormalities of T-lymphocytes in type 1 (insulin-dependent) diabetes. Diabetes 1983; 32: 91–4
   PubMedGoogle Scholar
• Peakman M, Hussain MJ, Millward BA, Leslie RDG, Vergani D. Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 (insulin dependent) diabetes. Diabetic Medicine 1990; 7: 327–30
   Google Scholar
• De Berardinis P, Londei M, Kahan M, Balsano F, Kon-Tianen S, Gale EAM. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4*. Clin Exp Immunol 1988; 73: 255–59
   PubMed Web of Science ®Google Scholar
• van Vliet E, Roep BO, Meulenbroek L, Bruining GJ, De Vries RRP. Human T cell clones with specificity for insulinoma cell antigens. Eur J Immunol 1989; 19: 213–16
   PubMed Web of Science ®Google Scholar
• Roep BO, Aarden SD, De Vries RRP, Hutton JC. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 1990; 345: 632–34
   PubMed Web of Science ®Google Scholar
• Roep BO, Kalian AA, De Vries RRP. p-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly-diagnosed IDDM patient. Diabetes 1992; 41: 1380–84
   PubMedGoogle Scholar
• Kontiainen S, James RFL, Feldmann M. Human islet cell induced T cell lines and clones from diabetic children. Autoimmunity 1991; 8: 193–7
   PubMed Web of Science ®Google Scholar
• National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–57
   Google Scholar
• Londei M, Bottazzo GF, Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
   PubMed Web of Science ®Google Scholar
• Wen L, Peakman M, Lobo-Yeo A, McFarlane BM, Mowat AP, Mieli-Vergani G. T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis. Lancet 1991; 336: 1527–30
   Google Scholar
• Peakman M, Buggins A, Nicolaides K, Layton DM, Vergani D. Analysis of lymphocyte phenotypes in cord blood from early gestation foetuses. Clin Exp Immunol 1992; 90: 345–50
   PubMed Web of Science ®Google Scholar
• Taswell C. Limiting dilution assays for determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614–19
   PubMed Web of Science ®Google Scholar
• Rhodes CJ, Campbell IL, Szopa TM, Biden TJ, Reynolds PD, Fernando ON. Effects of glucose and D-3-hydroxybutyrate on human pancreatic islet cell function. ClinSci 1985; 68: 567–72
   Google Scholar
• Peakman M, McNab GL, Heaton ND, Tan KC, Vergani D. Development of techniques for obtaining monodispersed human islet cells. Transplantation
   Google Scholar
• Peakman M, Vergani D. A new ELISA measuring antibodies to islet cell membranes: levels are increased in Type 1 diabetes. Horm Metab Res 1992; 26: 117–18
   Google Scholar
• Bottazo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendo-crine deficiencies. Lancet 1974; ii: 1279–83
   Google Scholar
• Palmer JP, Asplin CM, Clemens P, Lyen K, Tatpati O, Rahgu PK. Insulin antibodies in insulin dependent diabetics before insulin treatment. Science 1983; 222: 1337–39
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–56
   PubMed Web of Science ®Google Scholar
• Ludwig H, Schernthaner G, Tappeiner G, Mayr WR, Freyler H. Circulating immune complexes in insulin-dependent diabetes: analysis of incidence of islet cell antibodies, insulin autoantibodies HLA antigens, duration of disease and stages of diabetic retinopathy. Autoimmune aspects of endocrine disease, A Pinchera, D Doniach, GF Fenzi, L. Baschieri. Academic Press, London 1980; 313–318
   Google Scholar
• De Berardinis P, Londei M, James RFL, Lake SP, Wise PH, Feldmann M. Do CD4-positive cytotoxic T cells damage p cells in type 1 diabetes?. Lancet 1988; ii: 823–24
   Google Scholar
• Kontiainen S, Toomath R, Lowder J, Feldmann M. Selective activation of T cells in newly diagnosed insulin dependent diabetic patients: evidence for heterogeneity of T cell receptor usage. Clin Exp Immunol 1991; 83: 347–51
   PubMedGoogle Scholar
• Harrison LC, De Aizpura H, Loudovaris T, Campbell IL, Cebon JS, Tait BD. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin dependent diabetes. Diabetes 1991; 40: 1128–33
   Google Scholar
• Harrison LC, Chu SX, De Aizpura HJ, Graham M, Honey-Man MC, Colman PG. Islet-reactive T cells are a marker of preclinical insulin dependent diabetes. J. Clin Invest 1992; 89: 1161–65
   PubMedGoogle Scholar
• Atkinson MA, Kaufman DL, Campbell IL, Gibbs KA, Shah SC, Bu D-F. Response of peripheral blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339: 458–59
   PubMed Web of Science ®Google Scholar
• Zauderer M. Origin and significance of autoreactive T cells. Adv Immunol 1986; 45: 417–37
   Google Scholar
• Reich EP, Scaringe D, Yagi J, Sherwin RS, Janeway CA. title of paper Prevention g diabetes in NOD mice by injection g autoreactive T-lymphocytes. Diabetes 1989; 38: 1647–51
   PubMedGoogle Scholar
• Keystone E, Ritterhaus C, Wood N, Snow KM, Flatow J, Purvis JC. Elevation of a 78 T cell subset in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1991; 84: 78–82
   Google Scholar
• Wen L, Peakman M, Mieli-Vergani G, Vergani D. Elevation of activated yS-T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease. Clin Exp Immunol 1992; 89: 78–82
   PubMed Web of Science ®Google Scholar
• Hänninen A, Jalkanen S, Salmi M, Toikannen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin dependent diabetes mellitus. J Clin Invest 1992; 90: 1901–10
   PubMed Web of Science ®Google Scholar